Showing results (1351-1360 of 1,404) with videos related to

Sort By:
Pageof 141
Diabetes Care|June 22, 2025
Cardiovascular Outcomes and Efficacy of the PCSK9 Inhibitor Evolocumab in Individuals With Type 1 Diabetes: Insights From the FOURIER TrialYu Mi Kang, Robert P Giugliano, Xinhui Ran, et al.
Nature Communications|November 18, 2024
Improved safety of chimeric antigen receptor T cells indirectly targeting antigens via switchable adaptersHyung Bae Park, Ki Hyun Kim, Ju Hwan Kim, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|November 16, 2023
Changes in frailty among patients hospitalized for spine pathologies during the COVID-19 pandemic in Germany-a nationwide observational studyJulius Dengler, Hussain Gheewala, Clayton N Kraft, et al.
Journal of Korean Medical Science|July 18, 2023
Clinical Characteristics and Risk Factors for Mortality in Critical COVID-19 Patients Aged 50 Years or Younger During Omicron Wave in Korea: Comparison With Patients Older Than 50 Years of AgeHye Jin Shi, Jinyoung Yang, Joong Sik Eom, et al.
Plos One|February 9, 2019
Selection of an appropriate empiric antibiotic regimen in hematogenous vertebral osteomyelitisKi-Ho Park, Dong Youn Kim, Yu-Mi Lee, et al.
The Korean Journal of Internal Medicine|April 9, 2016
Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapyTark Kim, Yu-Mi Lee, Sang-Oh Lee, et al.
American Journal of Infection Control|June 19, 2021
Risk factors for isolation of multi-drug resistant organisms in coronavirus disease 2019 pneumonia: A multicenter studyHyo-Ju Son, Tark Kim, Eunjung Lee, et al.
Epidemiology and Health|August 24, 2018
Korea HIV/AIDS Cohort Study: study design and baseline characteristicsBo Youl Choi, Jun Yong Choi, Sang Hoon Han, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge regionYu Mi Ahn, Michael Clare, Carol L Ensinger, et al.
Emerging Infectious Diseases|August 2, 2016
Viral RNA in Blood as Indicator of Severe Outcome in Middle East Respiratory Syndrome Coronavirus InfectionSo Yeon Kim, Sun Jae Park, Sook Young Cho, et al.
Pageof 141